José Gabriel de Amores Carredano

Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA.

Entrepreneurial Ventures, Inc. sells wireless telephones, accessories and handsets. The company was incorporated on October 4, 1985 and is headquartered in Redwood City, CA.

Cogito Corp. provides software services for phone professionals. It offers technology, computer software and engineering services. The firm engages in the conversation and analyses human behavior through the smart phone. The company was founded by Vikram Sheel Kumar, Joshua Feast, Ali Azarbayejani and Alex Paul Pentland and is headquartered in Boston, MA.

TransparentBusiness, Inc. engages in the provision of online technology services. Its platform design to help clients increase freelancer productivity, protect client budgets from overbilling, allow coordination and monitoring of their work force, and provide real-time information on the cost and status of all tasks and projects. The company was founded by Alex Konanykhin and Silvina Moschini in 1997 and is headquartered in New York, NY.

Google LLC engages in the operation of internet portal and search index website. It provides online advertising technologies, search engine, cloud computing, and software solutions. The company was founded by Lawrence E. Page and Sergey Mikhaylovich Brin on September 4, 1998 and is headquartered in Mountain View, CA.

Universal Diagnostics SL is a bioinformatics and multi-omics company based in Seville, Spain. The Spanish company's mission is to transform cancer into a curable disease by developing blood tests that detect cancer in its earliest stages. The company's first single-draw blood test, Signal-C, accurately detects colorectal cancer with a sensitivity rate of 92%% and specificity rate of 97%%, with extraordinary accuracy for earlier stages (89%%/97%%). The company is developing Signal-X™, a multi-cancer platform able to detect various types of high-burden cancers with high sensitivity and tissue-of-origin specificity. With its multi-omics + computational biology + machine learning approach, the company is cracking the code to "true" early cancer detection, having identified the specific cfdna sequence regions that capture cancer's earliest signal with +90%% accuracy. The company was founded by Marko Bitenc and Juan Martínez Barea, with Juan Martínez Barea serving as the CEO since incorporation.